Callahan Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.8M | Sell |
562,533
-65,185
| -10% | -$1.74M | 1.32% | 27 |
|
|
2025
Q4 | $15.6M | Sell |
627,718
-86,079
| -12% | -$2.17M | 1.28% | 26 |
|
|
2025
Q3 | $18.2M | Buy |
713,797
+43,454
| +6% | +$1.07M | 1.54% | 17 |
|
|
2025
Q2 | $16.2M | Buy |
670,343
+94,846
| +16% | +$2.21M | 1.46% | 20 |
|
|
2025
Q1 | $14.6M | Buy |
575,497
+87,203
| +18% | +$2.28M | 1.39% | 24 |
|
|
2024
Q4 | $13M | Buy |
488,294
+69,155
| +16% | +$1.88M | 1.22% | 28 |
|
|
2024
Q3 | $12.1M | Buy |
419,139
+33,762
| +9% | +$985K | 1.18% | 29 |
|
|
2024
Q2 | $10.8M | Buy |
385,377
+94,140
| +32% | +$2.59M | 1.12% | 29 |
|
|
2024
Q1 | $8.08M | Buy |
291,237
+76,429
| +36% | +$2.12M | 0.85% | 42 |
|
|
2023
Q4 | $6.18M | Sell |
214,808
-86,499
| -29% | -$2.61M | 0.72% | 48 |
|
|
2023
Q3 | $9.99M | Sell |
301,307
-19,941
| -6% | -$705K | 1.26% | 29 |
|
|
2023
Q2 | $11.8M | Buy |
321,248
+2,662
| +0.8% | +$104K | 1.43% | 26 |
|
|
2023
Q1 | $13M | Sell |
318,586
-23,970
| -7% | -$1.04M | 1.68% | 22 |
|
|
2022
Q4 | $17.6M | Sell |
342,556
-15,799
| -4% | -$757K | 2.4% | 10 |
|
|
2022
Q3 | $15.7M | Sell |
358,355
-8,990
| -2% | -$437K | 2.25% | 9 |
|
|
2022
Q2 | $19.3M | Sell |
367,345
-15,534
| -4% | -$792K | 2.56% | 6 |
|
|
2022
Q1 | $19.8M | Sell |
382,879
-12,923
| -3% | -$671K | 2.26% | 7 |
|
|
2021
Q4 | $23.4M | Buy |
395,802
+37,059
| +10% | +$1.84M | 2.62% | 6 |
|
|
2021
Q3 | $15.4M | Buy |
358,743
+14,706
| +4% | +$651K | 1.94% | 11 |
|
|
2021
Q2 | $13.5M | Buy |
344,037
+4,819
| +1% | +$187K | 1.71% | 17 |
|
|
2021
Q1 | $12.3M | Buy |
339,218
+6,460
| +2% | +$229K | 1.66% | 21 |
|
|
2020
Q4 | $12.2M | Sell |
332,758
-23,892
| -7% | -$876K | 1.79% | 20 |
|
|
2020
Q3 | $12.4M | Buy |
356,650
+1,723
| +0.5% | +$60.4K | 2.03% | 17 |
|
|
2020
Q2 | $11M | Buy |
354,927
+13,141
| +4% | +$446K | 1.95% | 17 |
|
|
2020
Q1 | $10.6M | Buy |
341,786
+5,441
| +2% | +$185K | 2.22% | 16 |
|
|
2019
Q4 | $12.5M | Buy |
336,345
+5,941
| +2% | +$212K | 2% | 17 |
|
|
2019
Q3 | $11.3M | Buy |
330,404
+11,527
| +4% | +$419K | 1.97% | 18 |
|
|
2019
Q2 | $13.1M | Sell |
318,877
-544
| -0.2% | -$21.6K | 2.35% | 10 |
|
|
2019
Q1 | $12.9M | Buy |
319,421
+6,799
| +2% | +$272K | 2.4% | 7 |
|
|
2018
Q4 | $12.9M | Sell |
312,622
-3,392
| -1% | -$141K | 2.76% | 6 |
|
|
2018
Q3 | $13.2M | Buy |
316,014
+2,617
| +0.8% | +$101K | 2.45% | 7 |
|
|
2018
Q2 | $10.8M | Buy |
313,397
+4,343
| +1% | +$148K | 2.13% | 12 |
|
|
2018
Q1 | $10.4M | Buy |
309,054
+1,584
| +0.5% | +$54.5K | 2.13% | 11 |
|
|
2017
Q4 | $10.6M | Buy |
307,470
+2,046
| +0.7% | +$69.8K | 2.1% | 14 |
|
|
2017
Q3 | $10.3M | Buy |
305,424
+7,631
| +3% | +$245K | 2.18% | 11 |
|
|
2017
Q2 | $9.49M | Buy |
297,793
+3,375
| +1% | +$106K | 2.07% | 13 |
|
|
2017
Q1 | $9.56M | Buy |
294,418
+5,455
| +2% | +$172K | 2.15% | 14 |
|
|
2016
Q4 | $8.9M | Buy |
288,963
+12,548
| +5% | +$383K | 2.15% | 13 |
|
|
2016
Q3 | $8.88M | Buy |
276,415
+16,173
| +6% | +$541K | 2.22% | 13 |
|
|
2016
Q2 | $8.69M | Buy |
260,242
+138
| +0.1% | +$4.4K | 2.28% | 10 |
|
|
2016
Q1 | $7.31M | Buy |
260,104
+10,293
| +4% | +$294K | 2% | 20 |
|
|
2015
Q4 | $7.65M | Buy |
249,811
+12,792
| +5% | +$402K | 2.18% | 14 |
|
|
2015
Q3 | $7.06M | Buy |
237,019
+7,551
| +3% | +$242K | 2.17% | 13 |
|
|
2015
Q2 | $7.3M | Buy |
229,468
+1,875
| +0.8% | +$61.1K | 2.1% | 12 |
|
|
2015
Q1 | $7.51M | Buy |
227,593
+1,786
| +0.8% | +$56.8K | 2.19% | 6 |
|
|
2014
Q4 | $6.67M | Buy |
225,807
+1,307
| +0.6% | +$37.5K | 1.96% | 11 |
|
|
2014
Q3 | $6.3M | Buy |
224,500
+3,282
| +1% | +$92.1K | 1.95% | 11 |
|
|
2014
Q2 | $6.23M | Buy |
221,218
+7,783
| +4% | +$222K | 1.98% | 8 |
|
|
2014
Q1 | $6.5M | Buy |
213,435
+2,090
| +1% | +$62.3K | 2.21% | 4 |
|
|
2013
Q4 | $6.14M | Sell |
211,345
-725
| -0.3% | -$21.1K | 2.14% | 6 |
|
|
2013
Q3 | $5.78M | Buy |
212,070
+4,673
| +2% | +$127K | 2.2% | 4 |
|
|
2013
Q2 | $5.51M | Buy |
+207,397
| New | +$5.73M | 2.25% | 4 |
|
Other funds holding PFE
VCM
VPM
Callahan Advisors's PFE Position: Q1 2026 in Review
Callahan Advisors reduced its Pfizer (PFE) stake by 10% in Q1 2026, selling an estimated $1.74M and leaving 562,533 shares worth $15.8M. The position accounts for 1.32% of the portfolio, ranked #27.
Callahan Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.4M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Callahan Advisors held 562,533 shares of Pfizer worth $15.8M as of Q1 2026.
- Callahan Advisors sold 65,185 Pfizer shares in Q1 2026, an estimated $1.74M.
- Pfizer made up 1.32% of Callahan Advisors's portfolio in Q1 2026, its #27 holding.
- Callahan Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Callahan Advisors's Pfizer position peaked at $23.4M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Callahan Advisors's 13F filing for Q1 2026, filed 12 May 2026.